Last CNY9.07 CNY
Change Today -0.01 / -0.11%
Volume 20.5M
600285 On Other Exchanges
Symbol
Exchange
Shanghai
As of 2:05 AM 02/26/15 All times are local (Market data is delayed by at least 15 minutes).

henan lingrui pharmaceutic-a (600285) Snapshot

Open
CNY9.11
Previous Close
CNY9.08
Day High
CNY9.18
Day Low
CNY8.98
52 Week High
10/16/14 - CNY9.87
52 Week Low
04/28/14 - CNY5.81
Market Cap
4.9B
Average Volume 10 Days
14.7M
EPS TTM
CNY0.14
Shares Outstanding
535.6M
EX-Date
07/2/14
P/E TM
64.7x
Dividend
CNY0.10
Dividend Yield
1.10%
Current Stock Chart for HENAN LINGRUI PHARMACEUTIC-A (600285)

Related News

No related news articles were found.

henan lingrui pharmaceutic-a (600285) Related Businessweek News

No Related Businessweek News Found

henan lingrui pharmaceutic-a (600285) Details

Henan Lingrui Pharmaceutical Co., Ltd. is engaged in the production and sale of pharmaceutical products in China. The company offers pharmaceutical products in 10 dosage forms comprising adhesive plasters, tablets, capsules, granules, tinctures, etc. covering approximately 100 product varieties, such as Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, Shenqi Hypoglycemic capsules, and others. It provides patch, oral medicine, and other products. The company was founded in 1992 and is based in Xinyang, China.

henan lingrui pharmaceutic-a (600285) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

henan lingrui pharmaceutic-a (600285) Key Developments

Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Three Quarters of 2014

Henan Lingrui Pharmaceutical Co., Ltd. reported earnings results for the first three quarters of 2014. For the period, the company reported basic earnings per share of CNY 0.12 and weighted average return on net assets was 6.27%.

Henan Lingrui Pharmaceutical Co., Ltd., Board Meeting, Oct 28, 2014

Henan Lingrui Pharmaceutical Co., Ltd., Board Meeting, Oct 28, 2014. Agenda: To approve the proposal of changing its accounting policy; and to consider the text and full text of third quarter report of 2014.

Henan Lingrui Pharmaceutical Co., Ltd. to Report Q3, 2014 Results on Oct 30, 2014

Henan Lingrui Pharmaceutical Co., Ltd. announced that they will report Q3, 2014 results on Oct 30, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600285:CH CNY9.07 CNY -0.01

600285 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600285.
View Industry Companies
 

Industry Analysis

600285

Industry Average

Valuation 600285 Industry Range
Price/Earnings 63.1x
Price/Sales 6.0x
Price/Book 3.2x
Price/Cash Flow 64.0x
TEV/Sales 5.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HENAN LINGRUI PHARMACEUTIC-A, please visit www.lingrui.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.